← Leaderboards
Karamjit S Rai
Feinstein Institute For Medical Research
$186,058
Attributed
$186,058
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $97.1K · FY2005–08$100K$75K$50K$25K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$186,058 · 4
By mechanism
M01$186,058 · 4
Top collaborators
No co-investigators on record.
Most similar at Feinstein Institute For Medical Research
Same institution · by research overlap
- Anne Davidson$18,272,977
- Nicholas Chiorazzi$6,701,765
- Betty Diamond$68,537,262
- Jeffrey M Lipton$6,736,124
- Cynthia Aranow$1,565,219
Others in their field
Top investigators on “Biological Markers”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,644,754
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$297,689,086
- Lawrence Corey · Fred Hutchinson Cancer Center$297,689,086
- David R. Weir · University Of Michigan At Ann Arbor$286,732,935
- Jeffrey P Krischer · University Of South Florida$271,114,178
- David Heimbrook · Leidos Biomedical Research, Inc.$227,381,786
Research focus
Biological MarkersBone MarrowCell ProliferationCessation Of LifeChronic Lymphocytic LeukemiaComputer Retrieval Of Information On Scientific Projects DatabaseDisease ProgressionFundingGrantInstitutionIn VivoKineticsMeasurementPeripheral BloodPrognosticProspective StudiesResearch PersonnelResourcesSensitivity And SpecificitySourceUnited States National Institutes Of Health
Grant awards (4)
A CLL RESEARCH CONSORTIUM (CRC) PHASE II STUDY OF KINETIC BIOMARKERS$33,148
M01 · FY2008 · RR · contact PI
A CLL RESEARCH CONSORTIUM (CRC) PHASE II STUDY OF KINETIC BIOMARKERS$28,817
M01 · FY2007 · RR · contact PI
A CLL RESEARCH CONSORTIUM (CRC) PHASE II STUDY OF KINETIC BIOMARKER FOR CHRON$27,019
M01 · FY2006 · RR · contact PI
KINETIC BIOMARKER FOR CLL PROGNOSIS$97,074
M01 · FY2005 · RR